Cadrenal Therapeutics (CVKD) Short Interest Ratio & Short Volume → Proof that the Musk/Bezos rivalry is about to hit a new level (From InvestorPlace) (Ad) Free CVKD Stock Alerts $0.48 -0.01 (-2.16%) (As of 01:58 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Cadrenal Therapeutics Short Interest DataCurrent Short Volume173,700 sharesPrevious Short Volume42,000 sharesChange Vs. Previous Month+313.57%Dollar Volume Sold Short$70,348.50Short Interest Ratio / Days to Cover0.4Last Record DateApril 15, 2024Outstanding Shares16,008,000 sharesFloat Size8,530,000 sharesShort Percent of Float2.04%Today's Trading Volume64,411 sharesAverage Trading Volume359,449 sharesToday's Volume Vs. Average18% Short Selling Cadrenal Therapeutics ? Sign up to receive the latest short interest report for Cadrenal Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatCVKD Short Interest Over TimeCVKD Days to Cover Over TimeCVKD Percentage of Float Shorted Over Time Ad InvestorPlaceProof that the Musk/Bezos rivalry is about to hit a new levelElon Musk Humiliated Since Jeff Bezos and Elon Musk first met in 2004 — they've been involved in a bitter feud… from rockets, to electric vehicles to who's the world richest person…for going on two decades these two have been at each others throats…Go here now for full story. Cadrenal Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/2024173,700 shares $70,348.50 +313.6%2.0%0.4 $0.41 3/31/202442,000 shares $25,620.00 +91.8%0.5%0.1 $0.61 3/15/202421,900 shares $12,877.20 +204.2%0.4%0.1 $0.59 2/29/20247,200 shares $5,068.80 -69.8%0.1%0 $0.70 2/15/202423,800 shares $18,566.38 -87.9%0.4%0.1 $0.78 1/31/2024196,700 shares $357,994.00 +389.3%3.6%0.6 $1.82 Get the Latest News and Ratings for CVKD and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cadrenal Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/15/202440,200 shares $30,109.80 -38.7%0.7%0.3 $0.75 12/31/202365,600 shares $48,537.37 +28.9%1.2%0.9 $0.74 12/15/202350,900 shares $25,959.00 +50.6%0.9%0.9 $0.51 11/30/202333,800 shares $15,548.00 +38.5%0.6%0.9 $0.46 11/15/202324,400 shares $11,948.68 +101.7%0.5%0.5 $0.49 10/31/202312,100 shares $5,372.40 -63.4%0.3%0.2 $0.44 10/15/202333,100 shares $20,525.31 +126.7%0.7%0.5 $0.62 9/30/202314,600 shares $9,929.46 +1.4%0.3%0 $0.68 9/15/202314,400 shares $11,520.00 +65.5%0.3%0 $0.80 8/31/20238,700 shares $6,699.00 -82.3%0.2%0 $0.77 8/15/202349,100 shares $37,266.85 +16.4%1.2%0.1 $0.76 7/31/202342,200 shares $35,870.00 -90.2%1.4%0.1 $0.85 7/15/2023430,800 shares $555,688.92 +491.0%14.6%1.1 $1.29 6/30/202372,900 shares $110,079.00 +9.3%2.5%0.2 $1.51 6/15/202366,700 shares $101,384.00 -3.8%2.3%2.1 $1.52 5/31/202369,300 shares $98,406.00 -14.7%2.4%1.8 $1.42 5/15/202381,200 shares $114,492.00 No Change2.8%1.8 $1.41 CVKD Short Interest - Frequently Asked Questions What is Cadrenal Therapeutics' current short interest? Short interest is the volume of Cadrenal Therapeutics shares that have been sold short but have not yet been closed out or covered. As of April 15th, traders have sold 173,700 shares of CVKD short. 2.04% of Cadrenal Therapeutics' shares are currently sold short. Learn More on Cadrenal Therapeutics' current short interest. What is a good short interest percentage for Cadrenal Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.04% of Cadrenal Therapeutics' floating shares are currently sold short. Is Cadrenal Therapeutics' short interest increasing or decreasing? Cadrenal Therapeutics saw a increase in short interest in the month of April. As of April 15th, there was short interest totaling 173,700 shares, an increase of 313.6% from the previous total of 42,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Cadrenal Therapeutics' float size? Cadrenal Therapeutics currently has issued a total of 16,008,000 shares. Some of Cadrenal Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Cadrenal Therapeutics currently has a public float of 8,530,000 shares. How does Cadrenal Therapeutics' short interest compare to its competitors? 2.04% of Cadrenal Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Cadrenal Therapeutics: Pulmatrix, Inc. (0.32%), Pasithea Therapeutics Corp. (1.34%), Adial Pharmaceuticals, Inc. (26.72%), TFF Pharmaceuticals, Inc. (2.77%), Enveric Biosciences, Inc. (1.40%), Shuttle Pharmaceuticals Holdings, Inc. (0.77%), Vaccinex, Inc. (2.99%), Trevena, Inc. (0.33%), Xenetic Biosciences Inc (0.22%), Hepion Pharmaceuticals, Inc. (1.19%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Cadrenal Therapeutics stock? Short selling CVKD is an investing strategy that aims to generate trading profit from Cadrenal Therapeutics as its price is falling. CVKD shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Cadrenal Therapeutics? A short squeeze for Cadrenal Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CVKD, which in turn drives the price of the stock up even further. How often is Cadrenal Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CVKD, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Pulmatrix Short Interest Data Pasithea Therapeutics Short Interest Data Adial Pharmaceuticals Short Interest Data TFF Pharmaceuticals Short Interest Data Enveric Biosciences Short Interest Data Shuttle Pharmaceuticals Short Interest Data Vaccinex Short Interest Data Trevena Short Interest Data Xenetic Biosciences Short Interest Data Hepion Pharmaceuticals Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CVKD) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersThis 1 Biotech Stock has been shocking the marketsHuge Alerts1970’s computer coder Issues Shocking AI WarningInvestorPlaceDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDems have chosen Biden replacement?Paradigm Press348 million Americans lives to END as we know it?The Oxford ClubThe A.I. story nobody is telling you (Read ASAP)TradeSmithUrgent Nvidia WarningAltimetryThe Crypto 9-5 Escape PlanCrypto 101 Media